Lexaria Bioscience (LEXX) Asset Utilization Ratio (2018 - 2026)
Lexaria Bioscience (LEXX) posted Asset Utilization Ratio of 0.03 for Q2 2026, down 41.34% sequentially from 0.06 in Q1 2026, and down 56.9% YoY from 0.08 in Q2 2025.
Lexaria Bioscience (LEXX) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Lexaria Bioscience has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.03 in Q2 2026.
- Quarterly Asset Utilization Ratio fell 56.9% year-over-year to 0.03 in Q2 2026, while the trailing twelve-month figure through May 2026 was 0.03 (down 56.9% YoY) and the FY2025 annual result came in at 0.11, up 39.33% from the prior year.
- Asset Utilization Ratio slipped to 0.03 in Q2 2026 per LEXX's latest filing, from 0.06 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 2.83 in Q1 2023 and troughed at 0.02 in Q2 2022.
- A 5-year average of 0.28 and a median of 0.09 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio tumbled 95.25% in 2022, then surged 11600.83% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.09 in 2022, then soared by 103.86% to 0.17 in 2023, then plunged by 69.38% to 0.05 in 2024, then surged by 91.7% to 0.1 in 2025, then tumbled by 66.27% to 0.03 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.03, 0.06, and 0.1 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 0.03 |
| Feb 28, 2026 | 0.06 |
| Nov 30, 2025 | 0.10 |
| Aug 31, 2025 | 0.13 |
| May 31, 2025 | 0.08 |
| Feb 28, 2025 | 0.06 |
| Nov 30, 2024 | 0.05 |
| Aug 31, 2024 | 0.10 |
| May 31, 2024 | 0.14 |
| Feb 29, 2024 | 0.14 |
| Nov 30, 2023 | 0.17 |
| Aug 31, 2023 | 0.12 |
| May 31, 2023 | 0.94 |
| Feb 28, 2023 | 2.83 |
| Nov 30, 2022 | 0.09 |
| Aug 31, 2022 | 0.03 |
| May 31, 2022 | 0.02 |
| Feb 28, 2022 | 0.02 |
| Nov 30, 2021 | 0.04 |
| Aug 31, 2021 | 0.06 |